type 1 diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Autoimmune destruction of pancreatic beta cells leads to insufficient insulin production. The immune system mistakenly targets and attacks these insulin-producing cells, reducing the body’s ability to regulate blood glucose.

• Secondary mechanism: Loss of insulin results in increased blood glucose levels, as insulin is essential for facilitating glucose uptake into cells for energy. Without insulin, glucose remains in the bloodstream, leading to hyperglycemia.

• Key complication: Chronic hyperglycemia can cause vascular damage, increasing the risk of complications such as neuropathy, nephropathy, and retinopathy, which are critical considerations in patient management and education.

Patient Profile

Demographics:

35-year-old female, office administrator

History:

• Key past medical history: Diagnosed with type 1 diabetes at age 12; occasional episodes of hypoglycemia; family history of cardiovascular disease

• Current medications: Insulin glargine, insulin lispro, lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing episodes of blurry vision and foot pain over the past month

• Key symptoms: Fatigue, frequent urination, numbness in toes, and occasional dizziness

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 220 mg/dL

Section 1

Change in Patient Status:

During a follow-up appointment, the patient reports worsening of her symptoms. She notes that the blurry vision now occurs daily, and the foot pain has intensified, particularly at night. Additionally, she experiences tingling and burning sensations in her lower extremities, indicating potential progression of peripheral neuropathy. Upon physical examination, diminished vibratory sensation and decreased ankle reflexes are noted, suggesting further nerve involvement. Her blood pressure remains elevated at 150/92 mmHg, and her blood glucose level continues to be poorly controlled, now at 240 mg/dL.

These findings raise concern for potential diabetic retinopathy and peripheral neuropathy, both known complications of poorly managed type 1 diabetes. Given her family history of cardiovascular disease and her current hypertension, there is an increased risk for cardiovascular complications. The persistent hyperglycemia and hypertension may exacerbate these complications if not aggressively managed. The healthcare team considers adjusting her insulin regimen and emphasizes the importance of adherence to lifestyle modifications, such as diet and exercise, to manage her blood glucose levels effectively.

The patient's situation necessitates further diagnostic evaluations, including a comprehensive eye examination to assess for diabetic retinopathy and possible referral to a neurologist for nerve conduction studies. These steps will aid in confirming the extent of the complications and tailoring a more precise management plan. The patient is encouraged to monitor her blood glucose levels more frequently and report any new or worsening symptoms promptly. As the case unfolds, ongoing assessment and timely intervention will be crucial in preventing further progression of complications and improving the patient's quality of life.

Section 2

New Diagnostic Results:

Following the healthcare team's recommendation, the patient undergoes a comprehensive eye examination, which reveals early signs of diabetic retinopathy, characterized by microaneurysms and small areas of retinal hemorrhage. These findings confirm the need for immediate intervention to prevent further deterioration of her vision. Alongside, the patient is referred to a neurologist who conducts nerve conduction studies. The results indicate significant slowing of nerve signal transmission in the lower extremities, consistent with peripheral neuropathy. This finding correlates with her reported symptoms of tingling and burning sensations, reinforcing the diagnosis and the need for a targeted approach to manage her neuropathic pain.

Lab tests further reveal a concerning lipid profile, with elevated LDL cholesterol at 160 mg/dL and triglycerides at 220 mg/dL. These results, combined with her hypertension and family history of cardiovascular disease, heighten the concern for potential cardiac complications. Given these diagnostic results, the healthcare team decides to enhance her therapeutic regimen. An ophthalmologist is consulted for possible laser therapy to manage the retinopathy, while the neurologist recommends initiating a regimen of gabapentin to address the neuropathic pain. Additionally, a statin is prescribed to manage her dyslipidemia, and her insulin therapy is adjusted to improve glycemic control.

The patient is counseled on the importance of strict adherence to her medication regimen, dietary modifications to reduce cholesterol levels, and a structured exercise plan. She is also encouraged to attend a diabetes education program to gain better insights into managing her condition. The healthcare team schedules regular follow-ups to monitor her progress and make necessary adjustments to her treatment plan, aiming to stabilize her current conditions and prevent further complications. These measures are crucial in optimizing her health outcomes and maintaining her quality of life.

Section 3

As the patient adheres to her new therapeutic regimen and lifestyle modifications, the healthcare team closely monitors her progress through regular follow-up appointments. During one of these visits, the nurse conducts a thorough assessment, noting that the patient has been experiencing increased fatigue and intermittent episodes of dizziness. Her blood pressure measures at 150/95 mmHg, higher than her previous readings, indicating suboptimal control of her hypertension. A fingerstick blood glucose test reveals elevated levels at 190 mg/dL, suggesting that her glycemic control is not yet at the target level despite the adjusted insulin regimen.

Further laboratory tests are ordered to explore these findings. The results show an HbA1c level of 8.2%, confirming that her long-term glucose control is inadequate. In addition to the elevated cholesterol levels previously identified, these findings underscore the need for more aggressive management of her cardiovascular risk factors. The healthcare team discusses the potential for adjusting her antihypertensive medication and insulin therapy, considering her current symptoms and lab results. Additionally, they contemplate the introduction of a new diabetes medication, such as a GLP-1 receptor agonist, to help improve both her blood glucose levels and potentially aid in weight management.

Given these developments, the team emphasizes the importance of patient education, particularly in recognizing signs of hypoglycemia and understanding the impact of her diet and exercise on blood glucose levels. The patient is advised to maintain a detailed log of her blood pressure and blood glucose readings to aid in fine-tuning her treatment plan. These efforts aim to enhance her overall management strategy, reduce her risk of further complications, and support her journey toward achieving better health outcomes.

Section 4

A few weeks following the adjustment in her treatment plan, the patient returns for a follow-up appointment. During the initial assessment, the nurse notes that the patient appears more fatigued than on previous visits. She reports persistent dizziness, particularly upon standing, and mentions that she has been experiencing frequent nocturia. Vital signs reveal a blood pressure of 160/100 mmHg, indicating worsening hypertension. Her heart rate is slightly elevated at 92 beats per minute, and she has gained 5 pounds since her last visit, despite maintaining her dietary and physical activity recommendations.

Further investigation into her symptoms leads to the ordering of additional laboratory tests. Her electrolyte panel reveals mild hyponatremia with a sodium level of 132 mEq/L, and her creatinine level is slightly elevated at 1.4 mg/dL, suggesting potential early renal impairment. The urine microalbumin test is positive, confirming the presence of microalbuminuria, an early sign of diabetic nephropathy. These findings highlight the need for more aggressive management of her blood pressure and glycemic control to prevent further renal damage.

In response to these developments, the healthcare team considers intensifying her antihypertensive therapy, potentially adding an ACE inhibitor to address both her hypertension and protect her kidneys. Additionally, the introduction of a GLP-1 receptor agonist is revisited, not only to improve her glycemic control but also to assist in weight management. The patient is educated on the importance of medication adherence, the need for regular blood pressure and glucose monitoring, and recognizing symptoms of potential complications. Ongoing close monitoring of her renal function and blood pressure will be critical in adapting her treatment plan to mitigate the risk of further complications.

Section 5

A few weeks after implementing the intensified treatment plan, the patient returns for another follow-up visit. During the initial assessment, the nurse observes that the patient appears noticeably more lethargic and reports experiencing increased difficulty concentrating, with frequent episodes of blurred vision. She also mentions that her dizziness has intensified, now occurring not only upon standing but sporadically throughout the day. Her blood pressure remains elevated at 158/98 mmHg, and her heart rate is now at 98 beats per minute. Notably, the patient has lost 3 pounds since her last visit, which raises concerns given her previously documented weight gain.

Further laboratory tests are conducted to investigate these new symptoms. Her HbA1c level has decreased slightly to 7.8%, indicating some improvement in glycemic control. However, her electrolyte panel shows worsening hyponatremia with a sodium level of 130 mEq/L. Her serum potassium is at 3.1 mEq/L, reflecting hypokalemia, which could be contributing to her fatigue and dizziness. In light of these findings, there is increased suspicion of an adverse reaction to her new antihypertensive regimen, particularly the diuretic component, which may be exacerbating her electrolyte imbalances.

The healthcare team decides to adjust her medication regimen to address these issues. The diuretic is discontinued, and her dose of the ACE inhibitor is carefully adjusted to manage her blood pressure without further compromising her electrolyte balance. The team also emphasizes the importance of regular monitoring of her blood pressure and electrolytes, as well as educating the patient on signs of electrolyte disturbances. This approach is designed to stabilize her current condition and prevent additional complications, while continuously evaluating her response to the altered treatment plan.